U.S. flag

An official website of the United States government

NM_000540.3(RYR1):c.6502G>A (p.Val2168Met) AND not provided

Germline classification:
Pathogenic (2 submissions)
Last evaluated:
Sep 27, 2017
Review status:
1 star out of maximum of 4 stars
criteria provided, single submitter
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV000119656.1

Allele description

NM_000540.3(RYR1):c.6502G>A (p.Val2168Met)

Gene:
RYR1:ryanodine receptor 1 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
19q13.2
Genomic location:
Preferred name:
NM_000540.3(RYR1):c.6502G>A (p.Val2168Met)
HGVS:
  • NC_000019.10:g.38494579G>A
  • NG_008866.1:g.65880G>A
  • NM_000540.3:c.6502G>AMANE SELECT
  • NM_001042723.2:c.6502G>A
  • NP_000531.2:p.Val2168Met
  • NP_000531.2:p.Val2168Met
  • NP_001036188.1:p.Val2168Met
  • LRG_766t1:c.6502G>A
  • LRG_766:g.65880G>A
  • LRG_766p1:p.Val2168Met
  • NC_000019.9:g.38985219G>A
  • NM_000540.2:c.6502G>A
  • P21817:p.Val2168Met
  • p.(Val2168Met)
Protein change:
V2168M; VAL2168MET
Links:
PharmGKB: 1183705802PA164749136; PharmGKB: 1183705802PA449461; PharmGKB: 1183705802PA449845; PharmGKB: 1183705802PA450106; PharmGKB: 1183705802PA450434; PharmGKB: 1183705802PA451341; PharmGKB: 1183705802PA451522; UniProtKB: P21817#VAR_005603; OMIM: 180901.0013; dbSNP: rs118192176
NCBI 1000 Genomes Browser:
rs118192176
Molecular consequence:
  • NM_000540.3:c.6502G>A - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001042723.2:c.6502G>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Synonyms:
none provided
Identifiers:
MedGen: CN517202

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000154563Leiden Muscular Dystrophy (RYR1)
no classification provided
not providedunknownnot provided

PubMed (4)
[See all records that cite these PMIDs]

SCV000852713PreventionGenetics,PreventionGenetics
criteria provided, single submitter

(ACMG Guidelines, 2015)
Pathogenic
(Sep 27, 2017)
germlineclinical testing

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing
not providedunknownnot providednot providednot providednot provided1not providedliterature only

Citations

PubMed

Mutations in RYR1 in malignant hyperthermia and central core disease.

Robinson R, Carpenter D, Shaw MA, Halsall J, Hopkins P.

Hum Mutat. 2006 Oct;27(10):977-89. Review.

PubMed [citation]
PMID:
16917943

[Current aspects of the diagnosis of malignant hyperthermia].

Rüffert H, Olthoff D, Deutrich C, Froster UG.

Anaesthesist. 2002 Nov;51(11):904-13. Review. German.

PubMed [citation]
PMID:
12434264
See all PubMed Citations (5)

Details of each submission

From Leiden Muscular Dystrophy (RYR1), SCV000154563.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providednot provided PubMed (4)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1unknownnot provided1not providednot providednot providednot providednot providednot provided

From PreventionGenetics,PreventionGenetics, SCV000852713.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testing PubMed (1)
#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Jun 18, 2022